Quarterly report pursuant to Section 13 or 15(d)

NATURE OF BUSINESS AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Narrative) (Details)

v3.19.3
NATURE OF BUSINESS AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Narrative) (Details)
3 Months Ended 6 Months Ended
Sep. 30, 2019
USD ($)
customers
vendors
Sep. 30, 2018
USD ($)
customers
vendors
Sep. 30, 2019
USD ($)
customers
vendors
shares
Sep. 30, 2018
USD ($)
customers
vendors
shares
Mar. 31, 2019
USD ($)
Cash and cash equivalents $ 6,870,906   $ 6,870,906   $ 11,032,451
Selling expenses 1,496,708 $ 1,376,967 2,928,163 $ 2,900,243  
Lease liability 98,095   98,095    
Right of use asset 84,832   84,832    
Stock compensation expense $ 162,605   $ 1,266,345    
Accounts Receivable [Member]          
Number of major customers | customers     2 2  
Concentration Risk, Percentage     41.00% 33.00%  
Accounts Receivable [Member] | Customer 1 [Member]          
Concentration Risk, Percentage     23.00% 17.00%  
Accounts Receivable [Member] | Customer 2 [Member]          
Concentration Risk, Percentage     18.00% 16.00%  
Revenues [Member]          
Number of major customers | customers 2 2 2 2  
Concentration Risk, Percentage 41.00% 40.00% 41.00% 41.00%  
Revenues [Member] | Customer 1 [Member]          
Concentration Risk, Percentage 24.00% 24.00% 24.00% 22.00%  
Revenues [Member] | Customer 2 [Member]          
Concentration Risk, Percentage 17.00% 16.00% 17.00% 19.00%  
Purchases [Member]          
Number of major vendors | vendors 2 3 3 3  
Concentration Risk, Percentage 43.00% 58.00% 54.00% 58.00%  
Purchases [Member] | Vendor 1 [Member]          
Concentration Risk, Percentage 24.00% 33.00% 23.00% 35.00%  
Purchases [Member] | Vendor 2 [Member]          
Concentration Risk, Percentage 19.00% 13.00% 20.00% 12.00%  
Purchases [Member] | Vendor 3 [Member]          
Concentration Risk, Percentage   12.00% 11.00% 11.00%  
Employee Stock Option [Member]          
Antidilutive securities excluded from computation of earnings per share, amount | shares     493,144 1,738,216  
Warrant [Member]          
Antidilutive securities excluded from computation of earnings per share, amount | shares     422,821 3,203,303  
Convertible Preferred Stock [Member]          
Antidilutive securities excluded from computation of earnings per share, amount | shares     1,500,000 1,500,000